Loading chat...
IN SB0297
Bill
Status
3/21/2016
Primary Sponsor
Patricia Miller
Click for details
AI Summary
Senate Enrolled Act 297 - Summary
-
Requires Indiana Medicaid to cover counseling services, FDA-approved medications, and inpatient detoxification for opioid and alcohol dependence treatment, effective July 1, 2016.
-
Mandates opioid treatment programs obtain specific approval and certification from the division and comply with state and federal law, with separate certification required for each facility location.
-
Requires opioid treatment programs to be enrolled as Medicaid providers or maintain memoranda of understanding with community mental health centers beginning July 1, 2017.
-
Establishes rules for prior authorization of take-home opioid maintenance medications, minimum physician presence requirements, staffing standards, and annual diversion control plan submissions per federal regulations.
-
Requires comprehensive annual reporting by opioid treatment programs to the division on patient demographics, medications dispensed, treatment outcomes, and policies regarding controlled substance monitoring and illicit drug screening.
Legislative Description
Opioid dependence treatment. Requires Medicaid coverage for inpatient detoxification for the treatment of opioid or alcohol dependence. Adds requirements for an opioid treatment program to meet in order to operate in Indiana. Requires the division of mental health and addiction (division) to adopt specified administrative rules concerning opioid treatment by an opioid treatment provider. Requires the office of the secretary and the division to develop a treatment protocol containing best practice guidelines for the treatment of opiate dependent patients to be used by certain office based opioid treatment providers. Requires an opioid treatment program to provide specified information upon request
Last Action
Public Law 8
3/21/2016